These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 27477899

  • 1. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
    Pluchino LA, Choudhary S, Wang HC.
    Cancer Lett; 2016 Oct 10; 381(1):124-32. PubMed ID: 27477899
    [Abstract] [Full Text] [Related]

  • 2. Synergistic induction of cancer cell death and reduction of clonogenic resistance by cisplatin and FK228.
    Choudhary S, Sood S, Wang HC.
    Biochem Biophys Res Commun; 2013 Jun 28; 436(2):325-30. PubMed ID: 23743194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oncogenic H-Ras, FK228, and exogenous H2O2 cooperatively activated the ERK pathway in selective induction of human urinary bladder cancer J82 cell death.
    Choudhary S, Wang KK, Wang HC.
    Mol Carcinog; 2011 Mar 28; 50(3):215-9. PubMed ID: 21344509
    [Abstract] [Full Text] [Related]

  • 5. Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells.
    Choudhary S, Rathore K, Wang HC.
    J Cancer Res Clin Oncol; 2011 Mar 28; 137(3):471-80. PubMed ID: 20473523
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
    Hirokawa Y, Levitzki A, Lessene G, Baell J, Xiao Y, Zhu H, Maruta H.
    Cancer Lett; 2007 Jan 08; 245(1-2):242-51. PubMed ID: 16540233
    [Abstract] [Full Text] [Related]

  • 8. Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
    Pattarawat P, Hong T, Wallace S, Hu Y, Donnell R, Wang TH, Tsai CL, Wang J, Wang HR.
    Br J Cancer; 2020 Jul 08; 123(2):226-239. PubMed ID: 32390005
    [Abstract] [Full Text] [Related]

  • 9. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S, Sharma S, Vora J, Shah H, Srivastava A, Shrivastava N.
    J Ethnopharmacol; 2018 May 10; 217():23-35. PubMed ID: 29427634
    [Abstract] [Full Text] [Related]

  • 10. Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
    Punganuru SR, Madala HR, Arutla V, Srivenugopal KS.
    Carcinogenesis; 2018 Dec 13; 39(11):1399-1410. PubMed ID: 30010803
    [Abstract] [Full Text] [Related]

  • 11. Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer.
    Wilson AJ, Lalani AS, Wass E, Saskowski J, Khabele D.
    Gynecol Oncol; 2012 Dec 13; 127(3):579-86. PubMed ID: 23010348
    [Abstract] [Full Text] [Related]

  • 12. Synergistic induction of apoptosis by methylseleninic acid and cisplatin, the role of ROS-ERK/AKT-p53 pathway.
    Zhang Y, Zheng S, Zheng JS, Wong KH, Huang Z, Ngai SM, Zheng W, Wong YS, Chen T.
    Mol Pharm; 2014 Apr 07; 11(4):1282-93. PubMed ID: 24555485
    [Abstract] [Full Text] [Related]

  • 13. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
    Bellat V, Verchère A, Ashe SA, Law B.
    BMC Cancer; 2020 Jul 16; 20(1):661. PubMed ID: 32678032
    [Abstract] [Full Text] [Related]

  • 14. Chronic exposure to combined carcinogens enhances breast cell carcinogenesis with mesenchymal and stem-like cell properties.
    Pluchino LA, Wang HC.
    PLoS One; 2014 Jul 16; 9(11):e108698. PubMed ID: 25372613
    [Abstract] [Full Text] [Related]

  • 15. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.
    Zhang Z, Teruya K, Yoshida T, Eto H, Shirahata S.
    Mar Drugs; 2013 Jan 09; 11(1):81-98. PubMed ID: 23303302
    [Abstract] [Full Text] [Related]

  • 16. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT, Yu J, Wang HJ, Shi Y, Zhao TS, He BX, Qiao B, Feng ZW.
    Tumour Biol; 2017 May 09; 39(5):1010428317697562. PubMed ID: 28459209
    [Abstract] [Full Text] [Related]

  • 17. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
    Jeon WK, Choi J, Park SJ, Jo EJ, Lee YK, Lim S, Kim JH, Letterio JJ, Liu F, Kim SJ, Kim BC.
    Oncotarget; 2015 Dec 08; 6(39):41650-66. PubMed ID: 26497676
    [Abstract] [Full Text] [Related]

  • 18. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C, Vazquez-Martin A, López-Bonet E, Martín-Castillo B, Del Barco S, Brunet J, Menendez JA.
    Int J Oncol; 2008 Dec 08; 33(6):1165-76. PubMed ID: 19020749
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin and Pemetrexed Have Distinctive Growth-inhibitory Effects in Monotherapy and Combination Therapy on KRAS-dependent A549 Lung Cancer Cells.
    Mohiuddin M, Kasahara K.
    Cancer Genomics Proteomics; 2021 Dec 08; 18(4):579-590. PubMed ID: 34183390
    [Abstract] [Full Text] [Related]

  • 20. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z, Guo F, Albers AE, Sehouli J, Kaufmann AM.
    Biomed Pharmacother; 2019 May 08; 113():108727. PubMed ID: 30870721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.